OTCMKTS:WEDXF Westaim 3/27/2024 Earnings Report $19.00 +0.04 (+0.21%) As of 01:11 PM Eastern ProfileEarnings History Westaim EPS ResultsActual EPS$0.26Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AWestaim Revenue ResultsActual Revenue$1.67 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AWestaim Announcement DetailsQuarterDate3/27/2024TimeN/AConference Call DateN/AConference Call TimeN/AUpcoming EarningsWestaim's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Westaim Earnings HeadlinesWestaim Reports Q2 2025 Results for the Quarter Ended June 30, 2025August 21, 2025 | businesswire.comAM Best Assigns Credit Ratings to Ceres Life Insurance CompanyJuly 15, 2025 | businesswire.comBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging crypto — now called “Wall Street’s preferred choice” — with tech giants like Microsoft, Google, and Amazon already using it.October 14 at 2:00 AM | Weiss Ratings (Ad)The Westaim Corporation Reports Q1 2025 ResultsMay 14, 2025 | businesswire.comCC Capital and Westaim Complete Transaction, Creating Integrated Insurance and Asset Management PlatformApril 3, 2025 | businesswire.comWestaim Announces Receipt of Required Regulatory Approvals in Connection with CC Capital TransactionMarch 27, 2025 | businesswire.comSee More Westaim Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Westaim? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Westaim and other key companies, straight to your email. Email Address About WestaimWestaim (OTCMKTS:WEDXF) (OTCMKTS: WEDXF) is a Toronto-based investment firm focused on creating value through specialized credit, real estate and private equity strategies. The company operates as a capital allocator, partnering with experienced managers to deploy capital across a range of alternative asset classes. Westaim’s platform is designed to generate attractive risk-adjusted returns while maintaining a flexible mandate that can adapt to changing market conditions. Through its private equity activities, Westaim invests alongside established sponsors in opportunities spanning leveraged buyouts, growth equity and carve-out transactions. The firm’s real estate credit and specialty finance initiatives target senior and mezzanine lending to commercial and residential real estate projects in North America. By combining direct co-investment commitments with fund-of-one structures and secondary market purchases, Westaim seeks to balance yield generation with downside protection. Westaim is governed by an independent board of directors and a senior management team with deep experience in alternative investments, banking and risk management. The company places a strong emphasis on rigorous due diligence, disciplined portfolio construction and alignment of interests with its capital partners. Shares of Westaim trade on the OTC Markets under the symbol WEDXF, providing investors access to a diversified portfolio of alternative asset exposures through a single publicly traded vehicle.View Westaim ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff Concerns Upcoming Earnings ASML (10/15/2025)Abbott Laboratories (10/15/2025)Bank of America (10/15/2025)Kinder Morgan (10/15/2025)Morgan Stanley (10/15/2025)Progressive (10/15/2025)Prologis (10/15/2025)The PNC Financial Services Group (10/15/2025)CSX (10/16/2025)Interactive Brokers Group (10/16/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.